Loading stock data…
Nexentis Technologies Inc (NXTS)
$4.67-0.33 (-6.60%)
After Hours$4.48-0.19 (-4.07%)· Last close Jun 29
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Nexentis Technologies Inc. in the Basic Materials sector is trading at $4.67 with a market capitalization of $4M. The stock is currently near its 52-week low of $3.38, remaining 66.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0↑ | -$68,000↓ | $2,000 | $0 | $0 |
| Gross Profit | — | — | $0↑ | -$2,000↓ | $52,000 |
| Operating Income | -$2.28M↓ | -$587,000↑ | -$1.33M↑ | -$2.83M↓ | -$503,000 |
| Net Income | -$6.58M↓ | $1.27M↑ | $429,000↑ | -$4.51M↓ | -$1.19M |
Peer Comparison
Fundamentals
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes M...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.76M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-72.39%
Volume
Today's trading volume
1.11M
Recent News
Nexentis Shares Rise After Solar Project Monetisation Agreement (NXTS)
Nexentis Technologies Inc. (NASDAQ:NXTS) shares advanced 10% on Monday after the company announced the partial monetisation of its investment in the Melz solar project in Germany, based on a project valuation of US$14.
Top Midday Decliners
Wheeler Real Estate Investment Trust (WHLR) said in a regulatory filing that it is marketing 35 of i
Top Midday Gainers
Nexentis Technologies (NXTS) said Monday its subsidiary, MitoCareX Bio, has entered into an engageme